Rexulti Interactions
There are 600 drugs known to interact with Rexulti (brexpiprazole), along with 14 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 136 are major, 461 are moderate, and 3 are minor.
- View all 600 medications that may interact with Rexulti
- View Rexulti alcohol/food interactions (4)
- View Rexulti disease interactions (14)
Most frequently checked interactions
View interaction reports for Rexulti (brexpiprazole) and the medicines listed below.
- Abilify (aripiprazole)
- Adderall (amphetamine / dextroamphetamine)
- atorvastatin
- bupropion
- buspirone
- clonazepam
- Cymbalta (duloxetine)
- duloxetine
- gabapentin
- hydroxyzine
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- lamotrigine
- levothyroxine
- Lexapro (escitalopram)
- lisinopril
- melatonin
- metformin
- omeprazole
- pantoprazole
- prazosin
- propranolol
- Seroquel (quetiapine)
- trazodone
- Trintellix (vortioxetine)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Vyvanse (lisdexamfetamine)
- Wellbutrin XL (bupropion)
Rexulti alcohol/food interactions
There are 4 alcohol/food interactions with Rexulti (brexpiprazole).
Rexulti disease interactions
There are 14 disease interactions with Rexulti (brexpiprazole) which include:
- suicidality
- dementia
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- renal impairment
- weight gain
- hepatic impairment
- hyperprolactinemia
- tardive dyskinesia
Report options
QR code containing a link to this page
More about Rexulti (brexpiprazole)
- Rexulti consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (490)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
